Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

16.62 +0.32 (+1.93%)
Streaming Delayed Price Updated: 12:28 PM EDT, Sep 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,629,522
Open 16.51
Bid (Size) 16.62 (2)
Ask (Size) 16.63 (1)
Prev. Close 16.31
Today's Range 16.35 - 16.95
52wk Range 5.900 - 21.47
Shares Outstanding 88,140,978
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Intellia Highlights Clinical Improvements With One-Time Dose Of Experimental Drug
Intellia Therapeutics Inc. (NASDAQ: NTLA) on Thursday released longer-term follow-up data from the ongoing Phase 1 study of investigational nexiguran ziclumeran (nex-z) for the treatment of hereditary... 
Via Benzinga
The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property

Performance

YTD
+36.0%
+36.0%
1 Month
+46.4%
+46.4%
3 Month
+77.2%
+77.2%
6 Month
+133.8%
+133.8%
1 Year
-19.1%
-19.1%

More News

Read More
Tesla To Rally More Than 31%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Intellia Therapeutics Stock Gets A Price Target Hike From HC Wainwright – Check Out The Details
Via Stocktwits
Earnings Scheduled For August 7, 2025
Via Benzinga
Expert Outlook: Intellia Therapeutics Through The Eyes Of 5 Analysts
Via Benzinga
Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback
Via Benzinga
Topics ETFs Economy
Intellia Therapeutics Shares Are Ripping Higher: Here's Why
Via Benzinga
My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Cathie Wood Goes Bargain Hunting: She Just Bought 2 Stocks That Wall Street Thinks Will Climb 50% and 190%
Via The Motley Fool
Demystifying Intellia Therapeutics: Insights From 9 Analyst Reviews
Via Benzinga
Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
Walt Disney To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Intellia (NTLA) Q2 Revenue Jumps 106%
Via The Motley Fool
Intellia Therapeutics Inc (NASDAQ:NTLA) Q2 2025 Earnings: Revenue Surpasses Estimates, Losses Narrower Than Expected
Via Chartmill
INTELLIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Intellia Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?
Via Benzinga
Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook
Via MarketBeat
Topics Economy Stocks
FDA Approves KalVista's Ekterly As First Oral On-Demand Treatment For Rare Swelling Disease
Via Benzinga
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering
Via Benzinga
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
Via Benzinga
Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
Via Investor's Business Daily

Frequently Asked Questions

Is Intellia Therapeutics, Inc. - Common Stock publicly traded?
Yes, Intellia Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Intellia Therapeutics, Inc. - Common Stock trade on?
Intellia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Intellia Therapeutics, Inc. - Common Stock?
The ticker symbol for Intellia Therapeutics, Inc. - Common Stock is NTLA on the Nasdaq Stock Market
What is the current price of Intellia Therapeutics, Inc. - Common Stock?
The current price of Intellia Therapeutics, Inc. - Common Stock is 16.62
When was Intellia Therapeutics, Inc. - Common Stock last traded?
The last trade of Intellia Therapeutics, Inc. - Common Stock was at 09/29/25 12:28 PM ET
What is the market capitalization of Intellia Therapeutics, Inc. - Common Stock?
The market capitalization of Intellia Therapeutics, Inc. - Common Stock is 1.47B
How many shares of Intellia Therapeutics, Inc. - Common Stock are outstanding?
Intellia Therapeutics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.